Brown Shipley& CO LTD Bristol Myers Squibb CO Transaction History
Brown Shipley& CO LTD
- $305 Billion
- Q1 2024
A detailed history of Brown Shipley& CO LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Brown Shipley& CO LTD holds 7,544 shares of BMY stock, worth $313,302. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,544
Previous 7,632
1.15%
Holding current value
$313,302
Previous $392 Million
93.61%
% of portfolio
0.01%
Previous 0.19%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,554Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.73 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.75 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.8 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.69 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.92 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $88.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...